Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

DANA ASHLI DERISSI

Physician Assistants & Advanced Practice Nursing Providers Physician Assistant Medical

NPI
1063829505
CMS profile
10782134
Location
LA MESA, CA

General Payments · PY2021–2024

$3,159.39

  • Reported across 35 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$954.67

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $954.67 16

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $237.31 2
Inari Medical, Inc. $199.12 3
Lundbeck LLC $132.62 3
ABIOMED $131.09 1
Neurocrine BioSciences, Inc. $122.95 1
ABBVIE INC. $46.99 2
Collegium Pharmaceutical, Inc. $45.74 2
Virtus Pharmaceuticals LLC $24.30 1
PFIZER INC. $14.55 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $142.43 2
PY2022 $1,696.07 8
PY2023 $366.22 9
PY2024 $954.67 16

Payment records · PY2024 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $18.20 01/11/2024 Food and Beverage Undisputed 01/23/2026 1107013989 CMS
ABBVIE INC. $28.79 02/05/2024 Food and Beverage Undisputed 01/23/2026 1107013991 CMS
ABIOMED $131.09 06/05/2024 Food and Beverage Undisputed 01/23/2026 1142289901 CMS
AstraZeneca Pharmaceuticals LP $115.95 03/20/2024 Food and Beverage Undisputed 01/23/2026 1104329540 CMS
AstraZeneca Pharmaceuticals LP $121.36 08/08/2024 Food and Beverage Undisputed 01/23/2026 1105451572 CMS
Collegium Pharmaceutical, Inc. $24.91 03/14/2024 Food and Beverage Undisputed 01/23/2026 1135227931 CMS
Collegium Pharmaceutical, Inc. $20.83 08/15/2024 Food and Beverage Undisputed 01/23/2026 1135288885 CMS
Inari Medical, Inc. $17.24 09/01/2024 Food and Beverage Undisputed 01/23/2026 1140181876 CMS
Inari Medical, Inc. $164.64 09/26/2024 Food and Beverage Undisputed 01/23/2026 1140181878 CMS
Inari Medical, Inc. $17.24 10/10/2024 Food and Beverage Undisputed 01/23/2026 1140181880 CMS
Lundbeck LLC $33.33 05/15/2024 Food and Beverage Undisputed 01/23/2026 1146013351 CMS
Lundbeck LLC $91.66 05/15/2024 Food and Beverage Undisputed 01/23/2026 1146013353 CMS
Lundbeck LLC $7.63 09/05/2024 Food and Beverage Undisputed 01/23/2026 1146013355 CMS
Neurocrine Biosciences, Inc. $122.95 02/09/2024 Food and Beverage Undisputed 01/23/2026 1150921883 CMS
PFIZER INC. $14.55 03/21/2024 Food and Beverage Undisputed 01/23/2026 1131536259 CMS
Virtus Pharmaceuticals LLC $24.30 08/01/2024 Food and Beverage Undisputed 01/23/2026 1112837086 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.